C. Tejel et al. / Inorganica Chimica Acta 347 (2003) 129ꢂ
/
136
131
1
(ꢄ
trum: dꢀ
(2H) and 6.60 (m, 2H) (Phaꢂ
(m, 6H) (Phbꢂ
P); 6.96 (d, 1.4 Hz, 2H) and 6.76 (br s,
2H) (H4,5 Im); 7.15 (t, 7.2 Hz, 2H), 7.06 (t, 7.2 Hz, 4H)
and 6.29 (d, 7.2 Hz, 4H) (Ph ꢂCH2); 4.89 (dA, 2H) and
4.43 (dB, J(AꢂB)ꢀ15.0 Hz, 2H) (PhꢂCH2); 5.91 (m,
2H), 5.36 (m, 2H), 4.36 (m, 2H) and 4.14 (m, 2H) (ÄCH
/
50 8C, HDA) assigned from the H,1H-COSY spec-
8.70 (m, 2H), 7.97 (m, 2H), 7.88 (m, 2H), 7.68
P); 768 (m, 4H) and 7.54
Au(Ph2PBzIm)ꢁ).
C30H31N2Cl2PAuIr: 911. Found: 942.
Mol.
weight
Calc.
for
/
/
/
2.2.6. [RhCl(cod)(m-Ph2PBzIm)AuCl] (7)
Compound 7 was prepared as described for 6 starting
from [{Rh(m-Cl)(cod)}2] (34.5 mg, 0.07 mmol) and
[AuCl(Ph2PBzIm)] (80.5 mg, 0.14 mmol) to give yellow
needles of 7. Yield 80.5 mg (70%). Anal. Calc. for
/
/
/
/
/
cod); 3.26 (m, 2H), 3.12 (m, 2H), 2.76 (m, 4H), 2.44 (m,
4H) and 2.20 (m, 4H) (CH2 cod). 31P{1H} NMR
C30H31N2Cl2PAuRh×
/
CH2Cl2: C, 41.08; H, 3.67; N,
3.09. Found: C, 41.47; H, 3.49; N, 3.14%.
(ꢄ
(FABꢁ): 1193 (7%, Mꢁ
Rh(cod)(Ph2PBzIm)ꢁ). LM (2.6ꢃ
tone)ꢀ
205 S molꢄ1 cmꢄ1
/
50 8C, HDA): dꢀ
/
10.6 (d, J(Pꢂ
BF4ꢁ), 553 (100%,
10ꢄ4 M in ace-
/
Rh)ꢀ
/
146 Hz). MS
/
2.2.7. trans-[RhCl(CO)(Ph2PBzIm)2] (8)
/
To a solution of Ph2PBzIm (356.1 mg, 1.04 mmol) in
acetone (4 ml), solid [{Rh(m-Cl)(CO)2}2] (101.0 mg, 0.26
mmol) was added. The pale-yellow solid precipitated for
1 h was separated by filtration, washed with acetone
/
.
2.2.4. HT-[{Ir(m-Ph2PBzIm)(cod)}2](BF4)2 (5)
Compound 5 was prepared as described for 4 starting
from [{Ir(m-Cl)(cod)}2] (100.7 mg, 0.15 mmol), AgBF4
(58.4 mg, 0.30 mmol) and Ph2PBzIm (102.7 mg, 0.30
mmol) to rendered dark-blue needles corresponding to
5. Yield 197.2 mg (90%). Anal. Calc. for
C60H62N4B2F8P2Ir2: C, 49.39; H, 4.28; N, 3.84. Found:
(2ꢃ5 ml) and vacuum-dried. Yield 378.1 mg (83%).
/
Anal. Calc. for C45H38N4ClOP2Rh: C, 63.50; H, 4.50;
N, 6.58. Found: C, 63.43; H, 4.09; N, 6.36%. IR
(CH2Cl2, cmꢄ1) n(CO): 1982 (s). 1H NMR (25 8C,
CDCl3): dꢀ
7.1 (m, 20H, HmꢁpPh2Pꢁ
(d, 6.6 Hz, 4H, HoPh ꢂCH2), 6.86 (s, 2H, H5Im), 5.70 (s,
4H, Phꢂ 15.0
CH2). 31P{1H} NMR (25 8C, CDCl3): dꢀ
(d, J(PꢂRh)ꢀ125 Hz).
/
7.71 (dd, 12.6, 6.9 Hz, 8H, HoPh2P), 7.4ꢂ
/
/
HmꢁpPh ꢂ
/
CH2ꢁ
H4Im), 6.90
/
C, 49.21; H, 4.16; N, 3.79%. 1H NMR (ꢄ
/
50 8C, HDA)
assigned from the H,1H-COSY spectrum: dꢀ
8.56 (m,
2H), 7.92 (m, 2H), 7.71 (2H), 7.58 (2H) and 6.76 (m, 2H)
/
1
/
/
/
/
/
(Phaꢂ
/
P); 7.71 (m, 4H) and 7.58 (m, 6H) (Phbꢂ
P); 7.08
/
(d, 1.6 Hz, 2H) and 6.68 (br s, 2H) (H4,5 Im); 7.16 (t, 7.4
Hz, 2H), 7.07 (t, 7.4 Hz, 4H) and 6.31 (d, 7.4 Hz, 4H)
2.2.8. [{RhCl}2(m-CO)(m-Ph2PBzIm)2] (9)
The addition of solid [{Rh(m-Cl)(CO)2}2] (13.7 mg,
0.035 mmol) to a solution of trans-[RhCl(CO)(Ph2PB-
zIm)2] (8) (60.0 mg, 0.070 mmol) in dichloromethane
causes the immediate precipitation of a purple solid. The
resulting suspension was stirred overnight to give an
orange solution that was concentrated and carefully
(Ph ꢂ
Hz, 2H) (Phꢂ
2H) and 3.79 (m, 2H) (Ä
6H), 2.35 (m, 2H), 2.20 (m, 2H), and 1.95 (m, 4H) (CH2
cod). 31P{1H} NMR (ꢄ
50 8C, HDA): dꢀ0.85 (s). MS
(FABꢁ): 643 (100%, Ir(cod)(Ph2PBzIm)ꢁ). LM (2.6ꢃ
10ꢄ4 M in acetone)ꢀ211 S molꢄ1 cmꢄ1
/
CH2); 4.97 (dA, 2H) and 4.49 (dB, J(Aꢂ
CH2); 5.53 (m, 2H), 5.03 (m, 2H), 3.99 (m,
CH cod); 3.05 (m, 2H), 2.76 (m,
/
B)ꢀ
/
15.1
/
/
/
/
/
layered with diethyl ether to give brownꢂorange micro-
/
/
.
crystals. The solution was decanted, and the solid was
washed with diethyl ether and vacuum-dried. Yield 55.0
mg (75%). Anal. Calc. for C45H38N4Cl2OP2Rh2: C,
54.62; H, 3.87; N, 5.66. Found: C, 54.32; H, 3.72; N,
2.2.5. [IrCl(cod)(m-Ph2PBzIm)AuCl] (6)
Solid [{Ir(m-Cl)(cod)}2] (47.0 mg, 0.07 mmol) was
reacted with a solution of [AuCl(Ph2PBzIm)] (80.5 mg,
0.14 mmol) in dichloromethane (5 ml) for 30 min. The
resulting orange solution was concentrated to ca. 2 ml
and carefully layered with hexane to rendered orange
needles overnight. The crystals were washed with hexane
and vacuum-dried. Yield 102.0 mg (80%). Anal. Calc.
5.48%. IR (CH2Cl2, cmꢄ1) n(CO): 1778 (s). H NMR
1
(25 8C, CDCl3): dꢀ
8.07 (m, 4H, HoPhaP), 7.82 (m, 4H,
/
HoPhbP), 7.39 (m, 12H, Hm,pPh2P); 7.95 (d, 1.5 Hz, 2H)
and 6.72 (d, 1.5 Hz, 2H) (H4,5 Im); 7.09 (m, 6H) and 6.24
(d, 8.4 Hz, 4H) (Ph ꢂ
J(AꢂB)ꢀ15.0 Hz, 2H) (Phꢂ
(25 8C, CDCl3): dꢀ34.5 (AA? part from an AA?XX?
spin system).
/
CH2); 4.64 (dA, 2H) and 4.54 (dB,
/
/
/
CH2). 31P{1H} NMR
for C30H31N2Cl2PAuIr×
2.81. Found: C, 37.07; H, 3.21; N, 2.78%. H NMR
(25 8C, CDCl3): dꢀ7.73 (m, 2H), 7.60 (m, 2H), 7.58
(m, 3H), 7.36 (3H) (Ph2ꢂP); 7.70 (br s, 1H) and 6.96 (br
s, 1H) (H4,5 Im); 7.18 (m, 3H) and 6.58 (d, 6.9 Hz, 2H)
(Ph ꢂCH2); 4.47 (dA, 1H) and 4.52 (dB, J(AꢂB)ꢀ14.8
Hz, 1H) (PhꢂCH2); 4.91 (m, 1H), 4.80 (m, 1H), 3.22 (m,
1H) and 2.98 (m, 1H) (ÄCH cod); 2.61 (m, 1H), 2.41 (m,
2H), 2.09 (m, 1H), 2.01 (m, 1H), 1.59 (m, 1H) and 1.14
(m, 2H) (CH2 cod). 31P{1H} NMR (25 8C, CDCl3): dꢀ
16.3 (s). MS (FABꢁ): 910 (5%, Mꢁ), 875 (20%,
Mꢄ
Clꢁ), 642 (100%, Ir(cod)(Ph2PBzIm)ꢁ), 539 (90%,
/CH2Cl2: C, 37.40; H, 3.34; N,
/
1
/
/
2.2.9. [(CO)Cl2Rh(m-Ph2PBzIm)2PdCl] (10)
To a suspension of trans-[RhCl(CO)(Ph2PBzIm)2] (8)
(100 mg, 0.117 mmol) in dichloromethane (8 ml), solid
[PdCl2(NCMe)2] (45 mg, 0.117 mmol) was added to give
an orange solution almost inmediately. The solution was
concentrated to ca. 2 ml and carefully layered with 10 ml
of diethyl ether to give an orange microcrystalline solid.
The solid was separated by filtration, washed with
diethyl ether and vacuum-dried. Yield 102.6 mg (87%).
/
/
/
/
/
/
/